Literature DB >> 29936558

Chemical shift imaging with in-phase and opposed-phase sequences at 3 T: what is the optimal threshold, measurement method, and diagnostic accuracy for characterizing marrow signal abnormalities?

Neil M Kumar1,2, Shivani Ahlawat3, Laura M Fayad3,4,5.   

Abstract

OBJECTIVE: To determine the threshold signal drop on 3-T chemical shift imaging (CSI), with in-phase (IP) and opposed-phase (OP) sequences, for accurately identifying bone marrow replacement with 100% sensitivity, and determine a clinically useful measurement method for deriving such a threshold.
MATERIALS AND METHODS: From a convenience series of 157 MRIs, 36 cases with histologically proven marrow-replacing lesions and 22 sites of red marrow (histologically proven (2) or with minimum 6-month stability) with 3-Tesla CSI were included. Two musculoskeletal radiologists performed two measurement methods (first: multiple algorithmic ROIs at the top, middle, and bottom of lesions (M-ROI); second: an ROI was drawn where there appeared to be the least opposed-phase signal reduction qualitatively/visually (Q-ROI)). Lesional and red marrow signal change (%,[(IP-OP)signal/IP signal]*100) was determined. Statistical analyses included Student's t test, Cohen's kappa, and receiver operator characteristic curve generation.
RESULTS: By M-ROI, lesion signal change was - 0.508% (confidence interval (CI) = - 5.537:4.521) and 1.348% (CI = - 3.541:6.311) for readers 1 and 2. By Q-ROI, lesion signal change was - 11.03% (CI = - 17.01:- 5.046) and - 5.657% (CI = - 12.36:1.048) for readers 1 and 2. For all M-ROI and Q-ROI measurement strategies, signal change between lesional tissue and red marrow was significantly different (p < 0.0001). QROI produced the best composite sensitivities and specificities with a maximized Youden index of 0.955-1. A threshold signal drop of 25% with Q-ROI produced at least 100%/86% sensitivity/specificity for both readers for identifying marrow replacement.
CONCLUSIONS: For 3-T CSI, a single visually targeted measurement using a 25% threshold is accurate for identifying marrow-replacing lesions.

Keywords:  3 Tesla; Bone tumor; Chemical shift imaging; MRI; Marrow; Opposed-phase

Mesh:

Substances:

Year:  2018        PMID: 29936558     DOI: 10.1007/s00256-018-2999-0

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  24 in total

1.  Bone marrow fat quantification in the presence of trabecular bone: initial comparison between water-fat imaging and single-voxel MRS.

Authors:  Dimitrios C Karampinos; Gerd Melkus; Thomas Baum; Jan S Bauer; Ernst J Rummeny; Roland Krug
Journal:  Magn Reson Med       Date:  2014-03       Impact factor: 4.668

2.  Useful internal standards for distinguishing infiltrative marrow pathology from hematopoietic marrow at MRI.

Authors:  K W Carroll; J F Feller; P F Tirman
Journal:  J Magn Reson Imaging       Date:  1997 Mar-Apr       Impact factor: 4.813

3.  Interobserver variability of selective region-of-interest measurement protocols for quantitative diffusion weighted imaging in soft tissue masses: Comparison with whole tumor volume measurements.

Authors:  Shivani Ahlawat; Paras Khandheria; Filippo Del Grande; John Morelli; Ty K Subhawong; Shadpour Demehri; Laura M Fayad
Journal:  J Magn Reson Imaging       Date:  2015-07-14       Impact factor: 4.813

4.  Focal fat deposition in axial bone marrow: MR characteristics.

Authors:  P C Hajek; L L Baker; J E Goobar; D J Sartoris; J R Hesselink; P Haghighi; D Resnick
Journal:  Radiology       Date:  1987-01       Impact factor: 11.105

5.  Benign and malignant processes: normal values and differentiation with chemical shift MR imaging in vertebral marrow.

Authors:  Donald C Zajick; William B Morrison; Mark E Schweitzer; Joan Antoni Parellada; John A Carrino
Journal:  Radiology       Date:  2005-11       Impact factor: 11.105

6.  Utilization of chemical shift MRI in the diagnosis of disorders affecting pediatric bone marrow.

Authors:  Matthew Winfeld; Shivani Ahlawat; Nabile Safdar
Journal:  Skeletal Radiol       Date:  2016-05-14       Impact factor: 2.199

7.  In-phase and out-of-phase MR imaging of bone marrow: prediction of neoplasia based on the detection of coexistent fat and water.

Authors:  D G Disler; T R McCauley; L M Ratner; C D Kesack; J A Cooper
Journal:  AJR Am J Roentgenol       Date:  1997-11       Impact factor: 3.959

8.  Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT.

Authors:  Christopher J Hanrahan; Carl R Christensen; Julia R Crim
Journal:  Radiographics       Date:  2010-01       Impact factor: 5.333

9.  Chemical shift imaging at 3 Tesla: effect of echo time on assessing bone marrow abnormalities.

Authors:  F Del Grande; Ty Subhawong; A Flammang; L M Fayad
Journal:  Skeletal Radiol       Date:  2014-04-18       Impact factor: 2.199

10.  Value of opposed-phase gradient-echo technique in distinguishing between benign and malignant vertebral lesions.

Authors:  Virna Zampa; Mirco Cosottini; Chiara Michelassi; Simona Ortori; Luca Bruschini; Carlo Bartolozzi
Journal:  Eur Radiol       Date:  2001-12-18       Impact factor: 5.315

View more
  3 in total

Review 1.  The Dixon technique for MRI of the bone marrow.

Authors:  Niels van Vucht; Rodney Santiago; Bianca Lottmann; Ian Pressney; Dorothee Harder; Adnan Sheikh; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2019-07-15       Impact factor: 2.199

2.  Role of in-phase and out-of-phase chemical shift MRI in differentiation of non-neoplastic versus neoplastic benign and malignant marrow lesions.

Authors:  Niels van Vucht; Rodney Santiago; Ian Pressney; Asif Saifuddin
Journal:  Br J Radiol       Date:  2021-02-17       Impact factor: 3.039

3.  Do contrast-enhanced and advanced MRI sequences improve diagnostic accuracy for indeterminate lipomatous tumors?

Authors:  Brett A Shannon; Shivani Ahlawat; Carol D Morris; Adam S Levin; Laura M Fayad
Journal:  Radiol Med       Date:  2021-10-25       Impact factor: 3.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.